Biography
Tanya J. Fabian is Associate Professor of Pharmacy and Therapeutics and Psychiatry at the University of Pittsburgh. She received her PharmD degree from the University of Pittsburgh in 1998. A graduate of the Clinical Pharmaceutical Scientists Training Program, Dr. Fabian received her Doctor of Philosophy degree in Pharmaceutical Sciences in 2003. She also completed an NIH post doctoral research fellowship in clinical geriatric psychiatry under the mentorship of Drs. Patricia D. Kroboth and Dr. Bruce G. Pollock.Since 2006, Dr. Fabian has served as Director of Pharmacy Research and Pharmacy Services at Western Psychiatric Institute and Clinic and Residency Program Director for the PGY2 Psychiatric Pharmacy Residency Program. She became a Board Certified Psychiatric Pharmacy Specialist in 2008.
Honors / Awards
- "Paroxetine CR for prevention of anxiety and depression in patients with implantable cardioverter defibrillators
- Glaxo SmithKline
- Tanya J. Fabian, PhD.
- Treatment of Depression Following Cardiac Bypass Surgery
- NHLBI"
Research Interests
Interaction between stress and mental and physical health; genetic vulnerability to depression; prevention strategies.In the News

Tanya Fabian selected as a 2026 Fellow of AAPP
Congratulations to Dr. Tanya Fabian on being selected as a 2026 Fellow of the American Association of Psychiatric Pharmacists (AAPP)!...
Featured Publications

ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic planning guidance for pharmacy departments in hospitals and health systems
Am J Health Syst Pharm. 2026 Jan 6;83(2):71-101. DOI: 10.1093/ajhp/zxaf247. PMID: 41358375.

Long-acting injectable antipsychotic initiation in child and adolescent patients with psychiatric disorders
J Child Adolesc Psychopharmacol. 2025 Mar;35(2):80-86. doi: 10.1089/cap.2024.0024. Epub 2024 Aug 26. PMID: 39180437.

Comparison of psychiatric readmission rates for child and adolescent patients on long-acting injectable antipsychotics versus oral antipsychotics: A mirror study
J Child Adolesc Psychopharmacol. 2025 Mar;35(2):87-91. doi: 10.1089/cap.2024.0072. Epub 2024 Nov 29. PMID: 39611893.




